Yini i-Nilotinib: Ukusetshenziswa, Umthamo, Imiphumela Eceleni nokuningi

I-Nilotinib iyimithi yomdlavuza eqondiwe esiza ukwelapha izinhlobo ezithile zomdlavuza wegazi ngokuvimba amaprotheni athile aqhuba ukukhula kwamaseli omdlavuza. Le mithi kadokotela ingeyeqembu elibizwa ngokuthi ama-tyrosine kinase inhibitors, asebenza njengamashintshi amangqamuzana aqondile ukuvimbela amaseli omdlavuza ukuthi azande. Uma wena noma othile omkhathalelayo enikwe i-nilotinib, ukuqonda ukuthi isebenza kanjani nokuthi yini ongayilindela kungakusiza ukuthi uzizwe ulungiseleleke futhi uqiniseke ngalolu hambo lokwelashwa.

Yini i-Nilotinib?

I-Nilotinib iyimithi yomdlavuza yomlomo eyenzelwe ngqo ukwelapha i-chronic myeloid leukemia (CML), uhlobo lomdlavuza wegazi oluthinta amaseli amhlophe egazi. Cabanga ngayo njengokwelashwa okuqondiwe okuhlasela amaseli omdlavuza kuyilapho ngokuvamile ishiya amaseli anempilo yedwa. Le mithi iza ngama-capsule owathatha ngomlomo, okwenza kube lula kakhulu kunezinye izindlela eziningi zokwelapha umdlavuza ezidinga ukuvakashelwa esibhedlela.

Umuthi usebenza ngokuvimba iprotheni ethile engavamile ebizwa nge-BCR-ABL etshela amaseli omdlavuza ukuthi akhule futhi azande ngokungalawuleki. Ngokuvimbela le protein ukuthi ingasebenzi, i-nilotinib isiza umzimba wakho ukuthi uthole kabusha ukulawula ukukhiqizwa kwamaseli egazi. Ithathwa njenge-tyrosine kinase inhibitor yesizukulwane sesibili, okusho ukuthi iyinguqulo ethuthukisiwe yemithi efanayo yangaphambili.

Isetshenziselwani i-Nilotinib?

I-Nilotinib isetshenziswa ikakhulukazi ukwelapha i-chronic myeloid leukemia (CML) kubantu abadala abasesigabeni esingamahlalakhona noma esisheshisiwe sesifo. Udokotela wakho angase akubhale njengokwelashwa kokuqala uma usanda kutholakala, noma njengenketho yesibili uma eminye imithi ye-CML ingasebenzi kahle kuwe.

Lo muthi ulusizo olukhulu ikakhulukazi kubantu abanomdlavuza wegazi (leukemia) oye waba nokumelana ne-imatinib, omunye umuthi ovamile wokwelapha i-CML. Usetshenziswa futhi uma iziguli zingakwazi ukumelana ne-imatinib ngenxa yemiphumela engemihle. Kwezinye izimo, odokotela banikeza i-nilotinib ezigulini ezisanda kutholakala ukuthi zine-CML ezinama-genetic markers athile abonisa ukuthi zingase zisabele kangcono kulo muthi kunezinye izinketho.

Isebenza Kanjani I-Nilotinib?

I-Nilotinib isebenza ngokugxila embangweni oyinhloko we-chronic myeloid leukemia ezingeni le-molecular. Ku-CML, amaseli akho anechromosome engajwayelekile edala iphrotheni engalungile ebizwa nge-BCR-ABL, esebenza njengesignali ehlala ivuliwe etshela amaseli ukuthi aphindaphindeke ngokushesha.

Lo muthi uvimbela leyo phrotheni engalungile ekuthumeleni izimpawu zayo zokukhula, ngempumelelo ibeka amabhuleki ekukhiqizweni kwamaseli omdlavuza. Ithathwa njengomuthi oqinile futhi osebenza kahle kakhulu, ovame ukufeza lokho odokotela abakubiza ngokuthi “ukuxolelwa kwe-molecular” - okusho ukuthi umdlavuza awutholakali ekuhlolweni kwegazi. Lo muthi ukhethekile, okusho ukuthi ugxila ikakhulukazi kumaseli omdlavuza ngenkathi unethonya elincane kumaseli anempilo uma kuqhathaniswa ne-chemotherapy yendabuko.

Kufanele Ngiyithathe Kanjani I-Nilotinib?

Kufanele uthathe i-nilotinib ngendlela eqondile udokotela wakho ayiyalayo, ngokuvamile kabili ngosuku cishe ngamahora ayi-12 ahlukene. Umthetho obaluleke kakhulu ukuyithatha esiswini esingenalutho - akukho ukudla okungenani amahora ama-2 ngaphambi nangemva kwe-dose ngayinye. Lesi sikhathi sibalulekile ngoba ukudla kungakhuphula kakhulu inani lomuthi umzimba wakho owumuncayo, okungenzeka kuholele emiphumeleni engemihle eyingozi.

Gwinya amaphilisi wonke ngengilazi yamanzi egcwele, futhi ungalokothi uwavule, uwachoboze, noma uwahlafune. Uma unenkinga yokugwinya amaphilisi, khuluma nodokotela wakho ngezindlela ezingezinye kunokuzama ukuwalungisa wena uqobo. Kungcono ukuthatha imithamo yakho ngesikhathi esifanayo nsuku zonke ukuze ugcine amazinga aqhubekayo egazini lakho.

Gwema amagilebhisi nejusi lamagilebhisi ngokuphelele ngenkathi uthatha i-nilotinib, ngoba kungaphazamisa indlela umzimba wakho osebenzisa ngayo umuthi. Kufanele futhi uqaphele nezinye izithelo ze-citrus futhi uxoxe nganoma yiziphi izinkathazo zokudla neqembu lakho lezempilo.

Kufanele Ngiyithathe Isikhathi Esingakanani I-Nilotinib?

Abantu abaningi abane-CML badinga ukuthatha i-nilotinib iminyaka eminingana, futhi abaningi baqhubeka beyithatha unomphela njengokwelashwa kwesikhathi eside. Udokotela wakho uzoqapha impendulo yakho ngokuhlolwa kwegazi okujwayelekile kanye nama-biopsies omkholweni wamathambo ukuze anqume ukuthi umuthi usebenza kahle kangakanani nokuthi ungaqhubeka yini nohlelo lwamanje.

Ezinye iziguli eziqeda ukuthola ukuxolelwa okujulile komolekyuli zingase zigcine zikwazi ukuyeka ukwelashwa ngaphansi kokuqondiswa kwezokwelapha okucophelelayo, kodwa lesi sinqumo sidinga ukuqapha okukhulu futhi akufaneleki kuwo wonke umuntu. Umgomo ngokuvamile ukuzuza nokugcina ukuxolelwa, okuvame ukusho ukuhlala emuthini isikhathi eside.

Ungayeki ukuthatha i-nilotinib ngaphandle kokuxoxa ngayo nodokotela wakho kuqala, ngisho noma uzizwa kahle. Ukuyeka kungazelelwe kungavumela i-leukemia ukuthi ibuye ngokushesha futhi kube nzima ukuyelapha.

Yiziphi Imiphumela Eceleni Ye-Nilotinib?

Njengayo yonke imithi, i-nilotinib ingabangela imiphumela emibi, nakuba kungewona wonke umuntu oyitholayo. Ukuqonda ukuthi yini okufanele uyibheke kungakusiza ukuthi ulawule noma yiziphi izinkinga eziphakamayo futhi wazi ukuthi ungaxhumana nini neqembu lakho lezempilo.

Imiphumela emibi evame kakhulu ongase uyithole ihlanganisa isicanucanu, ukukhathala, ikhanda, nezinkinga zokugaya ukudla njengokuhuda noma ukuqunjelwa. Abantu abaningi baphawula nokuthuthuka kwesikhumba, ubuhlungu bemisipha namalunga, noma izinguquko ekubalweni kwegazi labo ezivela ekuhlolweni kwelabhorethri okuvamile. Le miphumela ivame ukulawuleka futhi ivame ukuthuthuka njengoba umzimba wakho ujwayela umuthi.

Ezinye izimo ezingathi sína zidinga ukunakekelwa kwezempilo ngokushesha. Lokhu kufaka phakathi izimpawu zezinkinga zenhliziyo njengobuhlungu besifuba, ukuphefumula kanzima, noma ukushaya kwenhliziyo okungajwayelekile. I-Nilotinib ingathinta ukushaya kwenhliziyo yakho, ngakho udokotela wakho uzokuqapha eduze ngama-electrocardiograms (EKGs) avamile. Kufanele futhi uqaphele izimpawu zezinkinga zesibindi njengokuphuzi kwesikhumba noma amehlo, umchamo omnyama, noma ubuhlungu obukhulu besisu.

Imiphumela emibi engavamile kodwa engathi sína ihlanganisa ukopha okukhulu, izimpawu zokutheleleka ngenxa yokwehla kwamaseli amhlophe egazi, noma izimpawu zikashukela ophezulu. Ithimba lakho lezempilo lizokuqapha njalo ngezivivinyo zegazi ukuze libambe noma yiziphi izinguquko ezikhathazayo ekuqaleni.

Ubani Ongafanele Athathwe I-Nilotinib?

Abanye abantu akufanele bathathe i-nilotinib ngenxa yengozi eyengeziwe yezinkinga ezingathi sína. Uma unomlando wezinkinga zokushaya kwenhliziyo, ikakhulukazi isimo esibizwa nge-long QT syndrome, lo muthi kungenzeka ungakuphephile. Abantu abanezifo zesibindi ezinzima noma labo abathatha imithi ethile esebenzisana ngobungozi ne-nilotinib kufanele futhi bayigweme.

Akufanele uthathe i-nilotinib uma ukhulelwe noma uncelisa, njengoba ingalimaza ingane yakho. Abesifazane abaneminyaka yokuzala badinga ukusebenzisa izindlela zokuvimbela inzalo eziphumelelayo ngesikhathi sokwelashwa kanye nesikhathi esithile ngemva kokuyeka umuthi. Amadoda athatha i-nilotinib kufanele futhi asebenzise izindlela zokuvimbela inzalo ukuvimbela ukukhulelwa kozakwabo.

Abantu abanezimo ezithile zofuzo ezithinta indlela imizimba yabo eprosesa ngayo imithi, isifo sezinso esinzima, noma labo abaye baba nokusabela okungalungile emithini efanayo kungenzeka bangabi ngabazali abahle bokwelashwa nge-nilotinib.

Igama Lomkhiqizo Le-Nilotinib

I-Nilotinib ithengiswa ngaphansi kwegama lomkhiqizo elithi Tasigna, elenziwa yi-Novartis. Le yindlela ejwayelekile ozohlangana nayo, nakuba izinguqulo ezivamile zingase zitholakale kwezinye izifunda. Umuthi uza ngesimo se-capsule ngamandla ahlukene, ngokuvamile ama-150 mg nama-200 mg.

Uma ugcwalisa umuthi wakho, qiniseka ukuthi ikhemisi likunika uhlobo olufanele noma uhlobo oluvunyelwe olujwayelekile njengoba kushiwo udokotela wakho. Amafomula ahlukene angaba namazinga ahlukene okumuncwa, ngakho ukuqina kubalulekile ekugcineni amazinga egazi azinzile.

Ezinye Izindlela Zokwelapha ze-Nilotinib

Eminye imithi eminingi ingelapha i-chronic myeloid leukemia uma i-nilotinib ingakulungele. I-Imatinib (Gleevec) ivame ukuba yindlela yokuqala yokwelapha i-CML esanda kutholwa futhi isasebenza kahle kubantu abaningi. I-Dasatinib (Sprycel) ingenye inketho yesizukulwane sesibili esisebenza ngendlela efana ne-nilotinib kodwa ingase ithuthukiswe kangcono ngabanye abantu.

Izinketho ezintsha zihlanganisa i-bosutinib (Bosulif) kanye ne-ponatinib (Iclusig), engasetshenziswa lapho ezinye izindlela zokwelapha zingasebenzi noma lapho umdlavuza usuthuthukise amaphethini athile okumelana. Udokotela wakho uzocabangela izinto ezinjengempilo yakho yonke, eminye imithi oyithathayo, nokuthi i-leukemia yakho isabela kanjani ukuze anqume enye indlela engcono kakhulu.

Ukukhetha phakathi kwale mithi kuvame ukuncika ezimweni zakho ngazinye, okuhlanganisa ukubekezelelana nemiphumela emibi, impilo yenhliziyo, nezici ezithile zofuzo ze-leukemia yakho.

Ingabe i-Nilotinib Ingcono Kune-Imatinib?

I-Nilotinib ne-imatinib zombili ziyindlela enhle yokwelapha i-CML, kodwa ngasinye sinamandla ahlukene. I-Nilotinib ngokuvamile inamandla kakhulu futhi ingakusiza ukuthi ufinyelele ekuthetheleleni okujulile ngokushesha kune-imatinib. Ezinye izifundo zikhomba ukuthi abantu abathatha i-nilotinib maningi amathuba okuthi bafinyelele emlandweni wokuthethelelwa kwe-molecular ngokushesha.

Kodwa-ke, "ngcono" kuncike esimweni sakho ngasinye. I-Imatinib isetshenziswe isikhathi eside futhi inesithombe sokuphepha esisungulwe kahle, kuyilapho i-nilotinib ingase ithwale izingozi eziphakeme zemiphumela emibi ethile, ikakhulukazi izinkinga ezihlobene nenhliziyo. I-Imatinib ivame ukuba lula ukuyibekezelela futhi ingathathwa nokudla, okwenza kube lula ngabanye abantu.

Udkt wakho uzocabangela izinto ezifana neminyaka yakho, impilo yonke, ukusebenza kwenhliziyo, nezintandokazi zakho siqu lapho enquma phakathi kwala makhambi. Zombili zisebenza kahle kakhulu ekulawuleni i-CML, ngakho-ke ukukhetha okungcono kakhulu yilokho okusebenza kahle ezimweni zakho ezithile.

Imibuzo Evame Ukubuzwa Mayelana ne-Nilotinib

Ingabe i-Nilotinib iphephile kubantu abanezifo zenhliziyo?

I-Nilotinib idinga ukucatshangelwa ngokucophelela uma unezifo zenhliziyo, njengoba ingathinta ukushaya kwenhliziyo futhi ingase yenze izimo zenhliziyo ezithile zibe zimbi. Udkt wakho cishe uzo-oda i-electrocardiogram (EKG) ngaphambi kokuqala ukwelashwa futhi aqaphe ukusebenza kwenhliziyo yakho njalo ngesikhathi sokwelashwa.

Uma unezifo zenhliziyo ezingatheni, ungase ukwazi ukuthatha i-nilotinib ngokuqapha okuseduze futhi mhlawumbe ulungise umthamo. Kodwa-ke, abantu abanezifo ezinzima zokushaya kwenhliziyo noma abahlaselwe yinhliziyo yamuva bangase badinge ezinye izindlela zokwelashwa. Udkt wakho wenhliziyo nodkt wakho womdlavuza bazosebenzisana ukuze banqume indlela ephephe kakhulu yesimo sakho.

Ngingenzani uma ngiphuthelwa ukuthatha i-Nilotinib eningi?

Uma ngengozi uthatha i-nilotinib eningi kunaleyo ebekiwe, xhumana nodkt wakho noma isikhungo sokulawula ubuthi ngokushesha, ngisho noma uzizwa ulungile. Ukuthatha okuningi kungaholela emiphumeleni emibi, okuhlanganisa izinguquko eziyingozi ekushayeni kwenhliziyo, isicanucanu esibi nokuhlanza, noma ukungajwayeleki kokubala kwegazi.

Ungalindi ukubona ukuthi izimpawu ziyavela yini - funa ukwelashwa ngokushesha. Letha ibhodlela lomuthi nawe egumbini lezimo eziphuthumayo ukuze abahlinzeki bezempilo bazi kahle ukuthi yini nokuthi ungakanani owathathayo. Esikhathini esizayo, cabangela ukusebenzisa umhleli wamaphilisi noma ukusetha izikhumbuzi zocingo ukusiza ekuvimbeleni ukweqisa ngengozi.

Ngingenzani uma ngiphuthelwa umthamo we-Nilotinib?

Uma uphuthelwa umthamo we-nilotinib, yithathe ngokushesha lapho ukhumbula, kodwa kuphela uma kungakapheli amahora angaphansi kwangu-6 kusukela ngesikhathi somthamo wakho ohleliwe. Uma sekudlule amahora angaphezu kwangu-6, weqa umthamo ophuthelwe bese uthatha umthamo wakho olandelayo ngesikhathi esijwayelekile. Ungalokothi uthathe imithamo emibili ngesikhathi esisodwa ukuze ulungise umthamo ophuthelwe.

Zama ukugcina izidingo zesisu esingenalutho ngisho nomthamo osekwephuzile - akukho ukudla amahora angu-2 ngaphambi nangemuva kwehora elingu-1 ngemva kokuthatha umuthi. Uma uvame ukukhohlwa imithamo, khuluma nodokotela wakho mayelana namaqhinga okukusiza ukuthi ukhumbule, njengezinhlelo zokusebenza ze-smartphone noma ukuxhuma imithamo emisebenzini yansuku zonke.

Ngingayeka nini Ukuthatha i-Nilotinib?

Isinqumo sokuyeka i-nilotinib siyinkimbinkimbi futhi kufanele senziwe kuphela ngesiqondiso sikadokotela wakho. Abantu abaningi abane-CML badinga ukuqhubeka nokwelashwa unomphela ukuze bagcine i-leukemia ekuxolelweni. Kodwa-ke, ezinye iziguli eziqeda ukuxolelwa kwe-molecular okujulile kakhulu zingaba ngabazongenela izivivinyo zokuxolelwa ngaphandle kokwelashwa.

Lezi zivivinyo zibandakanya ukuyeka umuthi ngenkathi kuqashwe eduze izimpawu zomdlavuza obuyayo. Cishe kuphela u-40-50% wabantu abazama lokhu abahlala ekuxolelweni ngaphandle kokwelashwa. Udokotela wakho uzocabangela izinto ezinjengokuthi sekuyisikhathi esingakanani ukuthi usukuxolelweni, amazinga akho okusabela kwe-molecular, nempilo yakho yonke lapho enquma ukuthi lokhu kungaba yini inketho kuwe.

Ngingathatha Eminye Imithi Ngenkathi ngise-Nilotinib?

Imithi eminingi ingasebenzisana ne-nilotinib, ngakho-ke kubalulekile ukutshela udokotela wakho ngakho konke okuthathayo, okuhlanganisa imithi kadokotela, imithi etholakala ngaphandle kwekhawunta, izithasiselo, kanye nemithi yezitshalo. Ezinye izindlela zokuxhumana zingaba yingozi, kanti ezinye zingase zidinge ukulungiswa komthamo noma ukuqapha okwengeziwe.

Imithi ethinta ukushaya kwenhliziyo ikhathaza kakhulu uma ihlanganiswe ne-nilotinib. Ezinye izibulala-magciwane, izibulala-fungus, kanye nemithi yenhliziyo kungase kudingeke ukuthi zigwenywe noma zisetshenziswe ngokuqapha okukhulu. Udokotela wakho nomuthi wakho bangakusiza ukuthi uhambe ngalezi zindlela zokuxhumana ngokuphepha futhi baphakamise ezinye izindlela uma kudingeka.